Company / Revenue per Share
Voyager Therapeutics, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$4.57
FY2025
5-year range
$0.93 / $4.57
FY2021-FY2025
Trend
+391.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +392% YoY in FY2025, a notable deviation from the 9-year average annual change of +169%.
Based on SEC 10-K filings.
4.57 in FY2025 with a 5-year CAGR of +85.7%.
Improved from $0.97 to $4.57 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- +85.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 391.8% year-over-year.
- Lowest revenue per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.57 | +391.8% |
| FY2024 | $0.93 | -4.1% |
| FY2023 | $0.97 | -78.5% |
| FY2022 | $4.51 | +61.6% |
| FY2021 | $2.79 | +1251.7% |
| FY2020 | $0.21 | -34.0% |
| FY2019 | $0.31 | -30.5% |
| FY2018 | $0.45 | -33.5% |
| FY2017 | $0.68 | -2.6% |
| FY2016 | $0.70 | -78.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026